Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Asset Utilization Ratio (2020 - 2026)

Kymera Therapeutics (KYMR) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.03 as the latest value for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio fell 51.41% year-over-year to 0.03; the TTM value through Mar 2026 reached 0.03, down 51.41%, while the annual FY2025 figure was 0.03, 52.43% down from the prior year.
  • Asset Utilization Ratio hit 0.03 in Q1 2026 for Kymera Therapeutics, up from 0.03 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.14 in Q4 2023 and bottomed at 0.03 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.08, with a median of 0.08 recorded in 2022.
  • Year-over-year, Asset Utilization Ratio surged 84.72% in 2023 and then tumbled 66.43% in 2024.
  • Kymera Therapeutics' Asset Utilization Ratio stood at 0.08 in 2022, then soared by 84.72% to 0.14 in 2023, then crashed by 66.43% to 0.05 in 2024, then plummeted by 41.06% to 0.03 in 2025, then increased by 9.46% to 0.03 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.03, 0.03, and 0.04 for Q1 2026, Q4 2025, and Q3 2025 respectively.